These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6715646)
1. Sequencing of behavior therapy and pharmacotherapy for obesity. Craighead LW J Consult Clin Psychol; 1984 Apr; 52(2):190-199. PubMed ID: 6715646 [No Abstract] [Full Text] [Related]
2. Behavioural management of obesity. Stunkard AJ Med J Aust; 1985 Apr; 142(SP7):S13-20. PubMed ID: 3884985 [No Abstract] [Full Text] [Related]
3. [Treatment of compulsive eating disorders in an autistic girl by combining behavior therapy and pharmacotherapy. Case report]. Hackler J Z Kinder Jugendpsychiatr; 1986; 14(3):220-7. PubMed ID: 3765895 [TBL] [Abstract][Full Text] [Related]
4. Anorectic effectiveness of differing dosage forms of fenfluramine. Tisdale SA; Ervin DK Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218 [No Abstract] [Full Text] [Related]
5. [Chronotherapy of obesity. II. Variations in eating behavior in the obese after fenfluramine treatment in relation to time of administration]. Di Vincenzo M; Guagnano MT; Della Loggia F; Sensi S Boll Soc Ital Biol Sper; 1982 Jun; 58(12):740-4. PubMed ID: 7104097 [TBL] [Abstract][Full Text] [Related]
6. Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Stunkard AJ; Craighead LW; O'Brien R Lancet; 1980 Nov; 2(8203):1045-7. PubMed ID: 6107677 [TBL] [Abstract][Full Text] [Related]
7. Behavior therapy and pharmacotherapy for obesity. Craighead LW; Stunkard AJ; O'Brien RM Arch Gen Psychiatry; 1981 Jul; 38(7):763-8. PubMed ID: 7247639 [TBL] [Abstract][Full Text] [Related]
9. Vitamin C and the anti-obesity effect of fenfluramine. Odumosu A; Wilson CW Int J Vitam Nutr Res; 1979; 49(3):251-63. PubMed ID: 528154 [TBL] [Abstract][Full Text] [Related]
10. Brain and nutrition. Dexfenfluramine weight control and regulation of eating patterns. Satellite symposium to the Collegium Internationale Neuro-Psychopharmacologicum, 15th C.I.N.P. congress. Puerto Rico, U.S.A., December 14-17, 1987. Proceedings. Clin Neuropharmacol; 1988; 11 Suppl 1():S1-223. PubMed ID: 3180105 [No Abstract] [Full Text] [Related]
11. Couples training, pharmacotherapy, and behavior therapy in the treatment of obesity. Brownell KD; Stunkard AJ Arch Gen Psychiatry; 1981 Nov; 38(11):1224-9. PubMed ID: 7305602 [TBL] [Abstract][Full Text] [Related]
12. Obesity--to treat or not to treat. Douglas JG; Ford MJ; Munro JF Scott Med J; 1979 Jan; 24(1):72-5. PubMed ID: 493935 [No Abstract] [Full Text] [Related]
13. A comparative trial of different regimens of fenfluramine and phentermine in obesity. Steel JM; Munro JF; Duncan LJ Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610 [No Abstract] [Full Text] [Related]
14. [Pharmacology and biochemistry of fenfluramine]. Duhault J Vie Med Can Fr; 1973; 2(2):141-7. PubMed ID: 4574870 [No Abstract] [Full Text] [Related]
15. [Long-term results of treatment of obesity]. Wechsler JG; Ditschuneit H Med Klin; 1980 Jul; 75(15):544-50. PubMed ID: 7001202 [No Abstract] [Full Text] [Related]
16. [Judicious use of anorectics]. Laurent-Jaccard A Schweiz Rundsch Med Prax; 1991 Feb; 80(6):116-7. PubMed ID: 2003174 [TBL] [Abstract][Full Text] [Related]
18. Behavioral and pharmacological treatments for obesity: an experimental comparison. Ost LG; Götestam KG Addict Behav; 1976; 1(4):331-8. PubMed ID: 998364 [No Abstract] [Full Text] [Related]
19. Plasma fenfluramine levels, weight loss and side effects: a failure to find a relationship. Pietrusko R; Stunkard A; Brownell K; Campbell DB Int J Obes; 1982; 6(6):567-71. PubMed ID: 7160955 [TBL] [Abstract][Full Text] [Related]
20. [A behaviorally oriented group therapy concept for the treatment of a risk group of obese patients]. Nutzinger DO; Cayiroglu S; Sachs G; Stellamor M; Zapotoczky HG Psychother Psychosom Med Psychol; 1983 Sep; 33 Suppl 2():102-9. PubMed ID: 6635142 [No Abstract] [Full Text] [Related] [Next] [New Search]